Markets

SCIENTURE To Provide REZENOPY To Addiction Treatment Centers

Sep 22, 2026 · 08:16 AM ET· updated 1h ago

Agreement provides dedicated commercial channel for REZENOPY™ across approximately 2,000 OTP (Opioid Treatment Program) Clinics and other Addiction Treatment Center Networks in the United StatesAccording to IQVIA data

Why It Matters

Scienture just signed a deal to sell its medicine to 2,000 addiction clinics. This gives the company a big new path to reach patients who need help.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

SCNX0.33

+0.03 (+8.96%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.